IGFBP-3 mediates TGFβ1 proliferative response in colon cancer cells

International Journal of Cancer

Volumn 87, Issue 3, 2000, Pages 373-378

  Kansra, Sanjay ^a   Ewton, Daina Z ^a   Wang, Jingping ^a   Friedman, Eileen ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; RETINOBLASTOMA PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

ADENOCARCINOMA; CELL DIVISION; COLONIC NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDES, ANTISENSE; RECOMBINANT PROTEINS; THIONUCLEOTIDES; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0034255738     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000801)87:3<373::AID-IJC10>3.0.CO;2-X     Document Type: Article

References (45)

1. ALEVIZOPOULOS, A. and MERMOD, N., TGFβ: the breaking open of a black box. BioEssays, 19, 581-591 (1997).
2. BACIUCHKA, M., REMACLE-BONNET, M., GARROUSTE, F., FAVRE, R., SASTRE, B. and POMMIER, G., IGFBP-3 proteolysis in patients with colorectal cancer: possible association with the metastatuc potential of the tumor. Int. J. Cancer, 79, 460-467 (1998).
3. BELLIS, S., NEWMAN, E. and FRIEDMAN, E., Steps in integrin β1-chain glycosylation mediated by TGFβ1 signaling through ras. J Cell Physiol. 181 (1999).
4. CAMACHO-HUBNER, C., BUSBY, W., MCCUSKER, R., WRIGHT, G. and CLEMMONS, D., Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J. Biol. Chem., 267, 11949-11956 (1992).
5. CHEN, X., WEISBERG, E., FRIDMACHER, V., WATANABE, M., NACO, G. and WHITMAN, M., Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature, 389, 85-89 (1997).
6. DENG, X., BELLIS, S., YAN, Z. and FRIEDMAN, E., Differential responsiveness to autocrine and exogenous TGFβ1 in cells with nonfunctional TGFβ receptor type III. Cell Growth Diff., 10 (1999).
7. DERYNCK, R., ZHANG, Y. and FENG, X.-H., Smads;transcriptional activators of TGFβ responses. Cell, 95, 737-740 (1998).
8. EL ATIQ, F., GARROUSTE, F., REMACLE-BONNET, M., SASTRE, B. and POMMIER, G., Alterations in serum levels of insulin-like growth factors and insulin-like growth factor binding proteins in patients with colorectal cancer. Int. J. Cancer, 57, 491-497 (1994).
9. FAN, D., CHAKRABARTY, S., SEID, C., BELL, C., SHACKERT, H., MORIKAWA, K. and FIDLER, I., Clonal stimulation or inhibition of human colon carcinomas and human renal carcinoma mediated by TGFβ1. Cancer Comm., 1, 117-125 (1989).
10. FRANZEN, P., TEN DIJKE, P., ICHIJO, H., YAMASHITA, H., SCHULTZ, P., HELDIN, D. and MIYAZONO, K., Cloning of a TGFβ type I receptor that forms a heterodimeric complex with the TGFβ type II receptor. Cell. 75, 681-692 (1993).
11. FRIEDMAN, E., GOLD, L., KLIMSTRA, D., ZENG, Z., WINAWER, S. and COHEN, A., High levels of TGFβ1 correlate with disease progression in human colon cancer. Cancer Epidemiol., 4, 549-554, (1995).
12. GUCEV, Z., OH, Y., KELLEY, K. and ROSENFELD, R., Cancer Res., 56, 1545-1550 (1996).
13. HAKEZ, M., HSU, S., YAN, Z., WINAWER, S. and FRIEDMAN, E., Two roles for TGFβ1 in colon enterocytic differentiation. Cell Growth Diff., 3, 753-762 (1992).
14. HAFEZ, M., INFANTE, D., WINAWER, S., FRIEDMAN , E., YAN, Z. and HSU, S., TGFβ1 acts as an autocrine negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation. Cell Growth Diff., 1, 617-626, (1990).
15. HERRERA, R., MAKELA, T. and WEINBERG, R., TGFβ-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol. Biol. Cell, 7, 1335-1342 (1996).
16. HOSSENLOPP, P., SEURIN, D., SEGOVIA-QUINSON, B., HARDOUIN, S. and BINOUX, M., Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding sites. Analyt. Biochem., 154, 138-143 (1986).
17. HSU, S., HUANG, F., HAFEZ, M., WINAWER, S. and FRIEDMAN, E., Colon carcinoma cells switch their response to TGFβ1 with tumor progression. Cell Growth Diff, 5, 267-275, (1994).
18. HUANG, F., NEWMAN, E., KERBEL, R. and FRIEDMAN, E., TGFβ1 is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGFβ1 antisense expression plasmid. Cell Growth Diff, 6, 1635-1642 (1995).
19. LEAL, S., HUANG, S. and HUANG, J., Interactions of the high affinity IGFBPs with the type V TGFβ receptor in mink lung epithelial cells. J. Biol. Chem., 274, 6711-6717 (1999).
20. LEAL, S., LIU, Q., HUANG, S. and HUANG, J., The type V TGFβ receptor is the putative IGFBP3 receptor. J. Biol. Chem., 212, 20572-20576 (1997).
21. LIN, H., WANG, X.-F., NG-EATON, E., WEINBERG, R. and LODISH, H., Expression cloning of the TGFβ type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68, 775-785 (1992).
22. LIU, F., POUPONNOT, C. and MASSAGUE, J., Genes Develop., 11, 3157-3167 (1997).
23. LIU, Q., HUANG, S. and HUANG, J., Function of the type V TGFβ receptor in TGFβ-induced growth inhibition of mink lung epithelial cells. J. Biol. Chem., 272, 18891-18895 (1997).
24. MARKOWITZ, S., WANG, J., MYEROFF, L., PARSONS, R., SUN, L., LUTTERBAUGH, J., FAN, R., ZBOROWSKA, E., KINZLER, K., VOGELSTEIN, B., BRATTAIN, M. and WILLSON, J., Inactivation of the typell TGFβ receptor in colon cancer cells with microsatellite instability. Science, 268, 1336-1338 (1995).
25. MULDER, K. and MORRIS, S., Activation of p21ras by TGFβ in epithelial cells. J. Biol. Chem., 267, 5029-5031 (1992).
26. OH, Y., MULLER, H., NG, L. and ROSENFELD, R., TGFβ induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein 3 action. J. Biol. Chem., 270, 13589-13592 (1995).
27. OH, Y., MULLER, H., PHAM, H. and ROSENFELD, R., Demonstration of receptors for IGFBP-3 on Hs578T human breast cancer cells. J. Biol. Chem., 272, 12181-12188 (1993).
28. PICON, A., GOLD, L.I., WANG, J., COHEN, A. and FRIEDMAN, E., A subset of metastatic human colon cancers expresses elevated levels of TGFβ1. Cancer Epidemiol., 7, 497-504 (1996).
29. RAJAH, R., VALENTINIS, B. and COHEN, P., 1GFBP3 induces apoptosis and mediates the effects of TGFβ1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem., 272, 12181-12188 (1997).
30. RIGGINS, G., KINZLER, K., VOGELSTEIN, B. and THAGALINGAM, S., Frequency of Smad gene mutations in human cancers. Can Res., 57, 2578-2580 (1997).
31. SCHROY, P., CARNRIGHT, K., WINAWER, S. and FRIEDMAN, E., Heterogenous responses of human colon carcinomas to HMBA. Cancer Res., 48, 5487-5484. (1988).
32. SCHROY, P., RIFKIN, J., COFFEY, R., WINAWER, S. and FRIEDMAN, E., Role of TGFβ1 in induction of colon carcinoma differentiation by HMBA. Cancer Res., 50, 261-265. (1990).
33. SHIBUYA, H., YAMAGUCHI, K., SHIRAKABE, K., TONEGAWA, A., GOTOH, Y., UENO, N., IRIE, K., NISHIDA, E. and MATSUMOTO, K., TAB1: an activator of the TAKI MAPKKK in TGFβ signal transduction. Science. 272, 1179-1182 (1996).
34. TSUKAZAKI, T., CHIANG, T., DAVISON, A., ATTISANO, L. and WRANA, J., SARA, a FYVE domain protein that recruits smad2 to the TGFβ receptor. Cell, 95, 779-791 (1998).
35. VENTURA, F., LIU, F., DOODY, J. and MASSAGUE, J., Interaction of the TGFβ receptor I with farnesyl-protein transferase a in yeast and mammalian cells. J. Biol. Chem., 271, 13931-13934 (1996).
36. WANG, T., DANIELSON, P., LI, B.-Y., SHAH, P., KIM, S. and DONAHOE, P., The p21ras farnesyltransferase: a subunit in TGFβ and activin signaling. Science, 211, 1120-1122 (1996).
37. WANG, T., DONAHOE, P. and ZERVOS, A., Specific interaction of type I receptors of the TGFβ family with the immunophilin FKBP-12. Science, 265, 674-676 (1994).
38. WRANA, J., ATTISANO, L., WIESER, R., VENTURA, F. and MASSAGUE, J., Mechanism of activation of the TGFβ receptor. Nature, 370, 341-347 (1994).
39. YAMAGUCHI, K., SHIRAKABE, K., SHIBUYA, H., IRIE, K., OISHI, I., UENO, N., TANIGUICHI, T., NISHIDA, E. and MATSUMOTO, K., Identification of a member of the MAPKKK family as a potential mediator of TGFβ signal transduction. Science. 270, 2008-2011 (1995).
40. YAMANAKA, Y., FOWLKES, J., WILSON, E., ROSENFELD, R. and OH, Y., Characterization of 1GFBP-3 binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. Endocrinology, 140, 1319-1328 (1999).
41. YAN, Z., HSU, S., WINAWER, S. and FRIEDMAN, E., TGFβ1 inhibits retinoblastoma gene expression but not pRB phosphorylation in TGFβ1-growth-stimulated colon carcinoma cells. Oncogene, 7, 801-805 (1992).
42. YAN, Z., WINAWER, S. and FRIEDMAN, E., Two different signal transduction pathways can be activated by TGFβ in epithelial cells. J. Biol. Chem., 269, 13231-13237. (1994).
43. YU, H., LEVESQUE, M., KHOSRAVI, M., PAPANASTASIOU-DIAMANDI, A., CLARK, G. and DIAMANDIS, E., IGFBP3 and breast cancer survival. Int. J. Cancer, 79, 624-628 (1998).
44. ZHANG, Y., FENG, X.-H. and DERYNCK, R., Smad3 and smad4 cooperate with c-jun/c-fos to mediate TGFβ-induced transcription. Nature. 394, 909-913 (1998).
45. ZOU, T., FLEISHER, A., KONG, D., YIN, J., SOUZA, R., WANG, S., SMOLINSKI, K., ABRAHAM, J. and MELTZER, S., Sequence alterations of IGFBP3 in neoplastic and normal gastrointestinal tissues. Cancer Res., 58, 4802-4804 (1998).